- Home
- Products
- Customized ADCs
- IL2RA
- Anti-IL2RA-PBD ADC
Anti-IL2RA-PBD ADC (CAT#: ADC-W-555)
This ADC product is comprised of an anti-IL2RA monoclonal antibody conjugated via a linker to PDB. The PDB is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, PDB binds to DNA, causes DNA damage.
- ADC Target
- ADC Antibody
- ADC payload drug
- Name
- IL2RA
- Alternative Names
- IL2RA; interleukin 2 receptor, alpha; p55; CD25; IL2R; TCGFR; IDDM10; interleukin-2 receptor subunit alpha; TAC antigen; IL-2R subunit alpha; IL-2 receptor subunit alpha;
- Target Entrez Gene ID
- 3559
- Target UniProt ID
- P01589
- Overview
- The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency.
- Overview
- Anti-IL2RA IgG1 Antibody
- Species Reactivity
- Human
- Name
- pyrrolobenzodiazepine (PBD) dimers
- Description
- Pyrrolobenzodiazepine (PBD) dimmers are highly cytotoxic DNA cross-linking agents. PBDs exert their biological activity through covalent binding via their N10-C11imine/carbinolamine moieties to the C2-amino position of a guanine residue within the minor groove of DNA.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD40LG (Dapirolizumab pegol)-SPDB-DM4 ADC (CAT#: ADC-W-2445)
- Anti-E. coli Stx1B (Pritoxaximab)-SMCC-DM1 ADC (CAT#: ADC-W-2012)
- Anti-EPHB2 -BMPEO-DM1 ADC (CAT#: ADC-W-153)
- Anti-IFNA1 (Rontalizumab)-SMCC-DM1 ADC (CAT#: ADC-W-1214)
- Anti-CD80 (Galiximab)-MC-MMAF ADC (CAT#: ADC-W-958)
- Anti-IL17A (Secukinumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1315)
- Anti-ERBB2 (Trastuzumab) Fab-bisAlk-VC-MMAE ADC (CAT#: ADC-W-404)
- Anti-Rabies Virus Glycoprotein (Rafivirumab)-MC-MMAF ADC (CAT#: ADC-W-1960)
- Anti-IL13 (Anrukinzumab)-SMCC-DM1 ADC (CAT#: ADC-W-1298)
- Anti-IL5 (Reslizumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1397)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-555. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-1370 | Anti-IL2RA (Daclizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-1363 | Anti-IL2RA (Inolimomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-1375 | Anti-IL2RA (Daclizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-1373 | Anti-IL2RA (Daclizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-1369 | Anti-IL2RA (Basiliximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| CAT# | Product Name | Linker | Payload |
| ADC-W-102 | Anti-DLL3-PBD dimers ADC-1 | pyrrolobenzodiazepine (PBD) dimers | |
| ADC-W-106 | Anti-DLL3-PBD dimers ADC-4 | pyrrolobenzodiazepine (PBD) dimers | |
| ADC-W-558 | Anti-DLL3-PBD ADC | pyrrolobenzodiazepine (PBD) dimers | |
| ADC-W-105 | Anti-DLL3-PBD dimers ADC-3 | pyrrolobenzodiazepine (PBD) dimers | |
| ADC-W-446 | Anti-CD70-Mc-VC-PBD ADC-5 | mc-VC (maleimidocaproyl-valine-citrulline) | pyrrolobenzodiazepine (PBD) dimers |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.